Health Canada has expanded the indication for clopidogrel [Plavix; sanofi-aventis, Bristol-Myers Squibb] to include patients with all acute coronary syndromes

Source: Inpharma, Volume 1, Number 1592, 2007-06-16 , pp. 23-23(1)

Publisher: Adis International

Keywords: Acute-coronary-syndromes, treatment; Aspirin, therapeutic use; Clopidogrel, therapeutic use; Development-status; Product-approvals

Document Type: Short communication

Publication date: 2007-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers